The Peterson Health Technology Institute (PHTI) conducted an independent evaluation of virtual mental health solutions to assess their clinical effectiveness and economic value.
These tools are emerging as scalable, accessible options to help close the persistent gap in treatment, despite increased screening efforts. Depression and anxiety affect more than 1 in 5 U.S. adults, and many still lack access to effective care.
Solutions Assessed:
-
Self-Guided: App-based content, sometimes with coaching
-
Prescription Digital Therapeutics (PDTs): FDA-cleared, clinician-supervised
-
Blended-Care: Combines digital tools with licensed virtual care teams
PHTI found that virtual solutions can significantly improve outcomes for people with mild to moderate depression and anxiety. However, while these tools may lower costs for individuals, some pricing models raise overall spending for employers and health plans.
To strengthen impact, the report recommends: improving long-term and comparative studies, enhancing user engagement, using stepped-care models for efficient delivery, and aligning payment with outcomes through value-based pricing.
